Temporal trends in spontaneous reporting of unlabelled adverse drug reactions

British Journal of Clinical Pharmacology

Volumn 44, Issue 3, 1997, Pages 299-301

  Haramburu, Françoise ^a,b   Bégaud, Bernard ^a   Moride, Yola ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

Spontaneous reporting; Unlabelled effects

Indexed keywords

ANOREXIGENIC AGENT; ANTIDEPRESSANT AGENT; ANTIMALARIAL AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPNOTIC AGENT; STOMACH SECRETION INHIBITOR; VASODILATOR AGENT;

ADVERSE DRUG REACTION; ARTICLE; DATA BASE; DRUG MARKETING; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; HUMAN; PRIORITY JOURNAL; PUBLICATION;

EID: 0030921158     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.t01-1-00573.x     Document Type: Article

References (5)

1. Speirs CJ. Prescription-related adverse reaction profiles and their use in risk-benefit analysis. In Iatrogenic diseases, 3rd ed. D'Arcy PF, Griffin JP Eds. Oxford: Oxford University Press, 1986: 93-101.
2. Weber JCP. Mathematical models in adverse drug reaction assessment. In Iatrogenic diseases, 3rd ed. D'Arcy PF, Griffin JP Eds. Oxford: Oxford University Press, 1986: 102-107.
3. Haramburu F, Tubert-Bitter P, Bégaud B. Trends in spontaneous reporting. Post-Marketing Surveillance 1992; 6: 129-134.
4. Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effects inattendus ou toxiques des médicaments. Therpie 1985; 40: 111-118.
5. Bégaud B, Péré JC, Miremont G. Estimation of the denominator in spontaneous reporting. In Methodological approaches in pharmacoepidemiology. Application to spontaneous reporting. Ed Arme-P. Amsterdam: Elsevier, 1993: 51-70.